---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-22-000170"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2022-10-27T23:59:59+00:00"
generated_at: "2026-06-22T23:30:33.060949+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q3 revenue $769.6M (+18% YoY); non-GAAP EPS $0.28; guides FY22 ~$2.88-2.91B

## Summary
- Revenue $769.6M, up 18% reported, 20% organic; US +17%, international +22% reported (+28% organic).
- GAAP net income $101.2M ($0.24 EPS); non-GAAP net income $111.9M ($0.28 EPS).
- Non-GAAP operating margin 20.9% (up 190 bps YoY); GAAP operating income $147.5M.
- Initiated international rollout of Dexcom G7 in UK, Ireland, Germany, Austria, Hong Kong.
- FY22 revenue guidance updated to ~$2.88-2.91B (18-19% growth); non-GAAP operating margin ~16%.

## SEC filing metadata
- accession: 0001093557-22-000170
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2022-10-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355722000170/0001093557-22-000170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355722000170/dxcm-20221027.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-22-000170
- JSON: https://secwatch.observer/filing/0001093557-22-000170.json
- Plain text: https://secwatch.observer/filing/0001093557-22-000170.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.